Cherington Charles

Across 1 filing between 2026, Cherington Charles, 10% Owner, has disclosed $4.7M in transactions — all concentrated in Ernexa Therapeutics Inc. (ERNA). Their disclosed trades are heavily weighted toward buying — $2.0M in buys and $0 in sells. The largest single open-market purchase on record is $2.0M in Ernexa Therapeutics Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.